US Patent Issued to Actym Therapeutics on Feb. 17 for "Engineered immunostimulatory bacterial strains and uses thereof" (California Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,047, issued on Feb. 17, was assigned to Actym Therapeutics Inc. (Berkeley, Calif.).

"Engineered immunostimulatory bacterial strains and uses thereof" was invented by Christopher D. Thanos (Tiburon, Calif.), Laura Hix Glickman (Oakland, Calif.) and Justin Skoble (Berkeley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are immunostimulatory bacteria and pharmaceutical compositions containing the bacteria. The immunostimulatory bacteria provided herein contain one or more modalities that enhance the anti-tumor activity of the immunostimulatory bacteria. Among the immunostimulatory bacteria provided are bacteria, such as Salmonella spec...